We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pozen Sues Teva Over Migraine Drug ANDA

Law360 (April 27, 2009, 12:00 AM EDT) -- Pharmaceutical company Pozen Inc. has sued Teva Pharmaceuticals USA Inc., alleging Teva infringed two patents by seeking regulatory approval of a generic version of the migraine treatment Treximet.

The suit, filed Friday in the U.S. District Court for the Eastern District of Texas, is the third suit pain-medication maker Pozen has filed in that court over the two patents.

According to the suit, Teva sent a letter to Pozen on April 14 saying it had submitted an abbreviated new drug application to the U.S. Food and...
To view the full article, register now.